US2011039928A1PendingUtilityA1

Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition

Individually held — no corporate assignee on recordPriority: Aug 13, 2009Filed: Aug 12, 2010Published: Feb 17, 2011
Est. expiryAug 13, 2029(~3 yrs left)· nominal 20-yr term from priority
A61K 31/23A61K 31/197A61K 31/231A61P 29/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An anti-inflammatory composition for treatment of inflamed joints. This composition includes an alkali buffered creatine and a cetylated fatty acid. The composition can be used for treating inflammation either by oral ingestion or by topical treatment.

Claims

exact text as granted — not AI-modified
I claim: 
     
         1 . An anti-inflammatory creatine composition comprising an alkali buffered creatine and a cetylated fatty acid. 
     
     
         2 . The composition according to  claim 1  wherein the cetylated fatty acid includes at least one of cetyl myristoleate, cetyl mylistate, cetyl palmitoleate, cetyl laureate, cetyl plamitate and cetyl oleate. 
     
     
         3 . The composition according to  claim 1  formed in a solid form capable of ingestion. 
     
     
         4 . The composition according to  claim 3  wherein the solid form is configured as at least one of a food supplement, a tablet, a granule and a capsule. 
     
     
         5 . The composition according to  claim 1  formed in a liquid form capable of ingestion. 
     
     
         6 . The composition according to  claim 1  suitable for being received by topical application. 
     
     
         7 . The composition according to  claim 6  suitable for being received by at least one of a suspension, an emulsion and a solution. 
     
     
         8 . The composition according to  claim 7  which is configured as at least one of an ointment, lotion, cream and gel.

Join the waitlist — get patent alerts

Track US2011039928A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.